Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release.

MLA

Ermer, James C., et al. “Bioavailability of Triple-Bead Mixed Amphetamine Salts Compared with a Dose-Augmentation Strategy of Mixed Amphetamine Salts Extended Release plus Mixed Amphetamine Salts Immediate Release.” Current Medical Research and Opinion, vol. 23, no. 5, May 2007, pp. 1067–75. EBSCOhost, https://doi.org/10.1185/030079907x182095.

APA

Ermer, J. C., Shojaei, A., Pennick, M., Anderson, C. S., Silverberg, A., & Youcha, S. H. (2007). Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release. Current Medical Research and Opinion, 23(5), 1067–1075. https://doi.org/10.1185/030079907x182095

Chicago

Ermer, James C, Amir Shojaei, Michael Pennick, Colleen S Anderson, Arthur Silverberg, and Sharon H Youcha. 2007. “Bioavailability of Triple-Bead Mixed Amphetamine Salts Compared with a Dose-Augmentation Strategy of Mixed Amphetamine Salts Extended Release plus Mixed Amphetamine Salts Immediate Release.” Current Medical Research and Opinion 23 (5): 1067–75. doi:10.1185/030079907x182095.